Background & aims The investigation was done to assess the impacts of probiotic
supplementation on movement and metabolic parameters in individuals with Parkinson's …

Parkinson's disease (PD) is mainly managed by pharmacological therapy (eg, Benserazide
and dopamine agonists). However, prolonged use of these drugs would gradually diminish …

The gut–brain axis is a hot topic in Parkinson's disease (PD). It has been postulated that gut
pathogens and dysbiosis can contribute to peripheral inflammatory states or trigger …

There is increasing evidence highlighting the potential role of the gut-brain axis in the
pathogenesis of Parkinson's disease (PD) and on the use of probiotics as a therapeutic …

Parkinson's disease (PD) is the second-most prevalent neurodegenerative or
neuropsychiatric disease, affecting 1% of seniors worldwide. The gut microbiota (GM) is one …

A pro-inflammatory intestinal microbiome is characteristic of Parkinson's disease (PD).
Prebiotic fibers change the microbiome and this study sought to understand the utility of …

Background: This study was conducted to evaluate the effects of probiotic supplementation
on gene expression related to inflammation, insulin and lipid in patients with Parkinson's …

Parkinson's disease (PD) is a neurodegenerative disease characterized by motor
impairment and the accumulation of alpha-synucleinopathy (α-syn), which can affect …

Background: Parkinson's disease (PD) is characterized by loss of dopaminergic neurons
and intraneuronal accumulation of alpha-synuclein, both in the basal ganglia and in …

Parkinson's disease (PD) is a complex neurological disorder classically characterized by
impairments in motor system function associated with loss of dopaminergic neurons in the …